Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03717584 · ClinicalTrials.gov registry record
A Cohort Study of the Intestinal Microbiota of Premature Infants
A clinical trial of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, sponsored by University of California, Davis.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT03717584 is a study of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 300 participants, above the 226-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03717584, a study of Bronchopulmonary Dysplasia and Necrotizing Enterocolitis, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Premature infants are at risk for a variety of diseases, the investigators would like to learn more about why some premature babies are at higher risk and some are protected from these diseases. Scientists at UC Davis and other universities have developed new ways to measure the bacteria and a large number of small molecules in specimens of infant blood, urine, stomach fluid and poop and in mother's milk. These discoveries allow us to consider questions that were impossible to answer before these new techniques were developed. One such question is whether the bacteria in the poop of a premature baby can help us predict the baby's risk for developing infection or a common and serious disease of premature infants called necrotizing enterocolitis. A second question is whether the DNA of a premature baby (obtained from saliva with a q-tip) can predict higher risk for diseases of premature babies.
Conditions Studied
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-12-23 |
| Est. Completion | 2027-03-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03717584
The ClinicalTrials.gov registry entry for NCT03717584 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 226-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (33% higher). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT03717584 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03717584 about?
NCT03717584 is a clinical study titled "A Cohort Study of the Intestinal Microbiota of Premature Infants". Premature infants are at risk for a variety of diseases, the investigators would like to learn more about why some premature babies are at higher risk and some are protected from these diseases. Scientists at UC Davis and other universities have developed new ways to measure the bacteria and a larg...
What is the current status of trial NCT03717584?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2018-12-23. Estimated completion is 2027-03-05.
What conditions does trial NCT03717584 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Growth Failure.
Who is sponsoring clinical trial NCT03717584?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03717584 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.